Fulgent Genetics, Inc.
US ˙ NasdaqGM ˙ US3596641098

SecurityFLGT / Fulgent Genetics, Inc.
InstitutionDimensional Fund Advisors Lp
Latest Disclosed Ownership671,664 shares
Latest Disclosed Value $ 10,678,638
Dimensional Fund Advisors Lp reports 24.45% decrease in ownership of FLGT / Fulgent Genetics, Inc.

On May 7, 2026 - Dimensional Fund Advisors Lp filed a 13F-HR form disclosing ownership of 671,664 shares of Fulgent Genetics, Inc. (US:FLGT) valued at $10,679,458 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 889,012 shares of Fulgent Genetics, Inc.. This represents a change in shares of -24.45% during the quarter. The current value of the position is $12,183,985 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-07 2026-03-31 13F FULGENT GENETICS COM 359664109 671,664 -217,348 -24.45 10,679 -54.28 0.0005
2026-02-12 2025-12-31 13F FULGENT GENETICS COM 359664109 889,012 -244,091 -21.54 23,355 -8.80 0.0049
2025-11-12 2025-09-30 13F FULGENT GENETICS COM 359664109 1,133,103 -1,319 -0.12 25,607 13.55 0.0055
2025-08-12 2025-06-30 13F FULGENT GENETICS COM 359664109 1,134,422 105,422 10.25 22,552 29.68 0.0052
2025-05-13 2025-03-31 13F FULGENT GENETICS COM 359664109 1,029,000 -16,815 -1.61 17,390 -9.97 0.0043
2025-02-13 2024-12-31 13F FULGENT GENETICS COM 359664109 1,045,815 -60,579 -5.48 19,316 -19.65 0.0046
2024-11-07 2024-09-30 13F FULGENT GENETICS COM 359664109 1,106,394 -109,834 -9.03 24,041 0.74 0.0058
2024-08-09 2024-06-30 13F FULGENT GENETICS COM 359664109 1,216,228 -128,791 -9.58 23,863 -18.24 0.0062
2024-05-10 2024-03-31 13F FULGENT GENETICS COM 359664109 1,345,019 -102,134 -7.06 29,187 -30.24 0.0079
2024-02-07 2023-12-31 13F FULGENT GENETICS COM 359664109 1,447,153 147,505 11.35 41,839 20.39 0.0122
2023-11-09 2023-09-30 13F FULGENT GENETICS COM 359664109 1,299,648 253,167 24.19 34,753 -10.32 0.0114
2023-08-09 2023-06-30 13F FULGENT GENETICS COM 359664109 1,046,481 192,932 22.60 38,752 45.44 0.0124
2023-05-12 2023-03-31 13F FULGENT GENETICS COM 359664109 853,549 55,223 6.92 26,645 115,747.83 0.0090
2023-02-09 2022-12-31 13F FULGENT GENETICS COM 359664109 798,326 117,504 17.26 24 -99.91 0.0070
2022-11-10 2022-09-30 13F FULGENT GENETICS COM 359664109 680,822 288,308 73.45 25,954 21.26 0.0100
2022-08-12 2022-06-30 13F FULGENT GENETICS COM 359664109 392,514 386,987 7,001.76 21,404 6,104.06 0.0077
2022-05-13 2022-03-31 13F FULGENT GENETICS COM 359664109 5,527 0 0.00 345 -37.95 0.0001
2022-02-09 2021-12-31 13F FULGENT GENETICS COM 359664109 5,527 182 3.41 556 15.59 0.0002
2021-11-12 2021-09-30 13F FULGENT GENETICS COM 359664109 5,345 -92,741 -94.55 481 -94.68 0.0002
2021-08-12 2021-06-30 13F FULGENT GENETICS COM 359664109 98,086 -8,458 -7.94 9,046 -12.12 0.0029
2021-05-14 2021-03-31 13F FULGENT GENETICS COM 359664109 106,544 -8,671 -7.53 10,294 71.48 0.0034
2021-03-08 2020-12-31 13F/A-2 FULGENT GENETICS COM 359664109 115,215 17,470 17.87 6,003 53.37 0.0022
2021-02-11 2020-12-31 13F FULGENT GENETICS COM 359664109 115,215 17,470 6,003 2,167.9645
2020-11-12 2020-09-30 13F FULGENT GENETICS COM 359664109 97,745 19,146 24.36 3,914 211.13 0.0017
2020-08-13 2020-06-30 13F FULGENT GENETICS COM 359664109 78,599 2,665 3.51 1,258 53.98 0.0006
2020-05-14 2020-03-31 13F FULGENT GENETICS COM 359664109 75,934 0 0.00 817 -16.63 0.0004
2020-02-14 2019-12-31 13F FULGENT GENETICS COM 359664109 75,934 6,736 9.73 980 36.30 0.0004
2019-11-12 2019-09-30 13F FULGENT GENETICS COM 359664109 69,198 2,850 4.30 719 62.30 0.0003
2019-08-13 2019-06-30 13F FULGENT GENETICS COM 359664109 66,348 381 0.58 443 12.72 0.0002
2019-08-12 2019-03-31 13F/A-2 FULGENT GENETICS COM 359664109 65,967 0 0.00 393 88.04 0.0002
2019-05-10 2019-03-31 13F FULGENT GENETICS COM 359664109 65,967 0 393
2019-02-26 2018-12-31 13F/A-1 FULGENT GENETICS COM 359664109 65,967 0 0.00 209 -19.31 0.0001
2019-02-13 2018-12-31 13F FULGENT GENETICS COM 359664109 65,967 0 209
2018-11-13 2018-09-30 13F FULGENT GENETICS COM 359664109 65,967 7,662 13.14 259 7.47 0.0001
2018-08-10 2018-06-30 13F FULGENT GENETICS COM 359664109 58,305 31,496 117.48 241 125.23 0.0001
2018-05-11 2018-03-31 13F FULGENT GENETICS COM 359664109 26,809 26,809 107 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.